PRRT2 and cancer: We have previously reported that the PKC GEMM, with the activated mutant Kras allele and inactivated p16 locus, can develop a full spectrum of PanIN lesions, which progress to invasive cancer and metastasis, mimicking human pancreatic tumorigenesis at both genetic and histologic levels (22).